Montco biopharm raises $20M Series B funding round

The company's initial target is a rare inherited condition that afflicts an estimated 130,000 people in the United States.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.